Equity - Biotechnology
Now's a bad time to buy biotech...says Pictet biotech manager
Sector specialist says major market events could prove problematic.
Funds & Fund Managers
All calculations in EUR, unless stated
| Average Manager Total Return : 9.6% (31 May 2017 - 31 May 2018) | ||||
|---|---|---|---|---|
| Total Return | ||||
| 1 of 5 |
|
11.8% |
||
| 2 of 5 |
|
10.7% |
||
| 3 of 5 |
|
9.2% |
||
| 3 of 5 |
|
9.2% |
||
| 5 of 5 |
|
7.0% |
||
Eleven selectors name their favourite team-run funds
Sometimes two heads are better than one but who are top fund buyers backing? Find out here.
The top eight natural resources managers revealed
Citywire Selector takes a closer look at the best-performing names in the sector over the past three years.
Nordea switches lead PM on emerging consumer fund
Lead manager steps back after one-year stint to assume analyst post.
What Devan Kaloo thinks you’re overlooking in EMs
Standard Aberdeen stalwart talks about developing world’s changing composition.
Political pitfalls punish JPM’s Europe Dynamic team
JPM’s John Baker says off-kilter stock calls were the reason for underperformance in the €1.5 billion fund.
Sector showdown: the top thematics managers over five years
Citywire Selectors puts top fund managers in the diverse sectorin the spotlight.